C

clarity-eye-center-ophthalmology

lightning_bolt Market Research

Clarity Eye Centre Ophthalmology: Company Profile



Background



Overview

Clarity Eye Centre is a publicly listed ophthalmology specialty medical group based in Hong Kong, established in 2005. The company offers a comprehensive range of ophthalmic services, including general consultations, cataract surgery, vision correction procedures, dry eye treatment, pediatric ophthalmology, and myopia control. With clinics located in Mong Kok and Central, Clarity Eye Centre is recognized as one of the leading ophthalmic brands in Hong Kong.

Mission and Vision

Clarity Eye Centre is dedicated to providing professional ophthalmic consultations and treatment services, aiming to enhance the quality of life for its patients through comprehensive eye care.

Industry Significance

As a prominent player in Hong Kong's ophthalmology sector, Clarity Eye Centre has established a strong market presence, offering specialized services that cater to a diverse patient base.

Key Strategic Focus



Core Objectives

  • To deliver comprehensive and specialized ophthalmic services.

  • To maintain a strong market presence in Hong Kong.

  • To integrate advanced technologies into clinical practices.


Areas of Specialization

  • Cataract surgery

  • Vision correction procedures (e.g., SILK™, SMILE®️pro, ICL implantable contact lenses)

  • Pediatric ophthalmology

  • Myopia control


Key Technologies Utilized

  • Sixth-generation ICL lenses

  • Femtosecond laser platforms


Primary Markets Targeted

  • Hong Kong

  • Greater Bay Area


Financials and Funding



Funding History

Clarity Eye Centre went public in 2022, marking a significant milestone in its financial development.

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly disclosed.

Notable Investors

Information about individual investors is not publicly available.

Utilization of Capital

The capital raised through public listing is intended to support the company's expansion plans, technological advancements, and service enhancements.

Pipeline Development



Key Pipeline Candidates

  • Advanced cataract surgery techniques

  • Innovative vision correction procedures


Stages of Development

Clarity Eye Centre is actively integrating advanced technologies into its clinical practices, with ongoing development in specialized ophthalmic services.

Target Conditions

  • Cataracts

  • Refractive vision errors

  • Pediatric eye conditions

  • Myopia


Anticipated Milestones

The company aims to achieve significant advancements in service offerings and patient outcomes through the integration of new technologies and procedures.

Technological Platform and Innovation



Proprietary Technologies

  • Sixth-generation ICL lenses

  • Femtosecond laser platforms


Significant Scientific Methods

  • Advanced diagnostic imaging

  • Customized treatment planning


AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, Clarity Eye Centre is committed to integrating advanced technologies to enhance patient care.

Leadership Team



Executive Profiles

  • Jiang Bo: Chief Executive Officer (CEO)

  • Professional Background: Appointed as CEO in 2024, Jiang Bo has led significant governance reforms and strategic initiatives to steer the company towards growth and stability.

  • Key Contributions: Implemented operational discipline, integrated insurance partnerships, and expanded the company's presence in the Greater Bay Area.


Competitor Profile



Market Insights and Dynamics

The ophthalmic services market in Hong Kong is competitive, with several established players offering a range of services. Clarity Eye Centre holds a significant market share, particularly in multifocal IOL replacement surgeries and ICL implantations.

Competitor Analysis

  • Hong Kong Sanatorium & Hospital: Leading in multifocal IOL replacement surgery revenue with a market share of 7.8% in 2020.

  • C-MER Eye Care Holdings Limited: A prominent eye center with a market share of 5.7% in multifocal IOL replacement surgeries in 2020.

  • Hong Kong Ophthalmic Associates: An established eye center with a market share of 4.9% in multifocal IOL replacement surgeries in 2020.


Strategic Collaborations and Partnerships

Clarity Eye Centre has established collaborations with institutions such as Wenzhou Medical University to strengthen its talent pipeline and enhance research capabilities.

Operational Insights

Clarity Eye Centre differentiates itself through the integration of advanced technologies, a comprehensive range of specialized services, and a strong market presence in Hong Kong.

Strategic Opportunities and Future Directions

The company aims to expand its services in the Greater Bay Area, integrate insurance partnerships to enhance service delivery, and continue adopting innovative technologies to improve patient outcomes.

Contact Information



  • Official Website: Clarity Eye Centre

  • Social Media:

  • Facebook: Clarity Eye Centre

  • Instagram: @clarityeyecentre

  • LinkedIn: Clarity Eye Centre

Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI